5-O-[BETA-D-APIOFURANOSYL-(1->6)-BETA-D-GLUCOPYRANOSYL]-7-METHOXY-3',4'-DIHYDROXY-4-PHENYLCOUMARIN
Compound with spectra: 1 NMR
![5-O-[BETA-D-APIOFURANOSYL-(1->6)-BETA-D-GLUCOPYRANOSYL]-7-METHOXY-3',4'-DIHYDROXY-4-PHENYLCOUMARIN](/api/compound/GSu7vE5QLD0.png?ph=true&h=300&w=458 "5-O-[BETA-D-APIOFURANOSYL-(1->6)-BETA-D-GLUCOPYRANOSYL]-7-METHOXY-3',4'-DIHYDROXY-4-PHENYLCOUMARIN")
| SpectraBase Compound ID | GSu7vE5QLD0 |
|---|---|
| InChI | InChI=1S/C27H30O15/c1-37-11-5-15-20(12(7-19(31)39-15)10-2-3-13(29)14(30)4-10)16(6-11)40-27-25(36)23(34)22(33)18(42-27)9-38-26-24(35)21(32)17(8-28)41-26/h2-7,17-18,21-30,32-36H,8-9H2,1H3 |
| InChIKey | DNJYNIYVOMRIEU-UHFFFAOYSA-N |
| Mol Weight | 594.52 g/mol |
| Molecular Formula | C27H30O15 |
| Exact Mass | 594.15847 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
KOUITCHENSIDE_G;1-O-[BETA-D-GLUCOPYRANOSYL-(1->6)BETA-D-GLUCOPYRANOSYL]-3,5-DIMETHOXYXANTHONE
3,5-DIMETHOXY-1-O-PRIMEVEROSYL-XANTHONE
5-HYDROXY-3-METHOXY-1-O-PRIMEVEROSYL-XANTHONE
LUTEOLIN-3'-BENZOYL-5-O-[BETA-D-GLUCOPYRANOSYL-(1->6)-BETA-D-GLUCOPYRANOSIDE]
7,8-DIHYDROXY-3-METHOXY-1-O-PRIMEVEROSYL-XANTHONE
TRIPTEXANTHOSIDE-B;#2;1,2,6,8-TETRAHYDROXYXANTHONE-1-O-GENTIOBIOSIDE;1,2,6,8-TETRAHYDROXYXANTHONE-1-O-(6'-O-BETA-D-GLUCOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE
QUERCETIN-3-METHYLETHER-7-O-ALPHA-L-ARABINOFURANOSYL-(1->6)-BETA-D-GLUCOPYRANOSIDE
4',6,7-TRIHYDROXY-6-METHOXYISOFLAVONE-7-O-BETA-D-XYLOPYRANOSYL-(1->6)-BETA-D-GLUCOPYRANOSIDE
(-)-7-O-METHYLEUCOMOL-5-O-BETA-NEOHESPERIDOSIDE
DIOSMETIN-7-O-(2'',6''-DI-O-ALPHA-L-RHAMNOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE
| Title | Journal or Book | Year |
|---|---|---|
| Antihyperglycemic Effect of Constituents fromHintonia standleyanain Streptozotocin-Induced Diabetic Rats | Planta Medica | 2005 |